We are committed to finding a safe, effective, and patient-friendly therapy for food and pediatric allergy patients

 

OLFUS-VIPES Results

Latest News

DBV Technologies Announces Financial Calendar 2017

DBV Technologies Presents its Half-year Statement of the Liquidity Contract

Documentation

20-F Form 2015

Agenda

LEERINK Partners 6th Annual Global Healthcare Conference

New York, USA

EAACI Congress 2016

The EAACI (European Academy Allergy and Clinical Immunology) Congress took place in Vienna from June 11th to 15th.

Epicutaneous Immunotherapy